myExtraContent1
myExtraContent5

Dr. Bernd Eisele
CEO

Dr. Leander Grode
CSO and Director Business Development

Dr. Christiane Meller
Project Manager and Quality Assurance Manager

Dr. Steffi Hansen
Project Manager and Quality Assurance Manager

Dr. Katharina Brett
Clinical Project Manager

Dr. Gerald P. Parzmair
Project Manager

Dr. Fabio Pisano
Project Manager

Dr. Kathrin Schulte
Clinical Project Manager

Dr. Rosalie Ridzewski
Project Manager

Dr. Inci Aydin
Project Manager

Inge Jacobi
Accounting and Controlling

Christoph Schütz
Team Assistant

Career
Open positions
Bernd Eisele M.D. is CEO since 2008 and CSO (Head of Research & Development) of VPM since 2003.

From 1997-2002 he was Medical Director and Head of Medical Marketing of Region 6 in Solvay Pharmaceuticals GmbH, Hannover. Region 6 comprised Canada, Asia, the Middle East, India, Australia, and South Africa. Bernd was responsible for the planning and conduct of local and region-wide marketing campaigns for Solvay’s influenca vaccine and for its cardiovascular, gastroenterology, gynecology, and psychiatry products.

Additionally, Bernd planned and supervised the company’s pivotal trials within the Region which were needed for local registrations (e.g., for PR China). In 2002, he was appointed Global Product Director for psychiatry and became responsible for the world-wide marketing of Solvay Pharmaceuticals’ psychiatry products. Bernd had joined Solvay in 1996 and was responsible for the international phase III development program of one of Solvay´s leading cardiovascular products.

Bernd Eisele began his career in the industry as a Clinical Project Manager at Behringwerke AG in 1988. In various positions Bernd was responsible for the clinical development of recombinant and transgenic products in clinical phases I – III.

Bernd Eisele holds a doctorate in medicine from Heidelberg Medical University (1986).
myExtraContent7
myExtraContent8